Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
1.720
-0.070 (-3.91%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Karyopharm Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $3.68 | Buy | Maintains | $3.68 | +113.95% | Sep 1, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $8 | Buy | Maintains | $8 | +365.12% | Aug 13, 2026 |
| Jefferies | Jefferies | Buy Maintains $14 → $11 | Buy | Maintains | $14 → $11 | +539.53% | Jul 31, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jul 31, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $16 → $7 | Buy | Maintains | $16 → $7 | +306.98% | Jul 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades $13 → $3 | Hold | Downgrades | $13 → $3 | +74.42% | Jul 31, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Hold Reiterates $5 → $7 | Hold | Reiterates | $5 → $7 | +306.98% | May 15, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $28 | Buy | Initiates | $28 | +1,527.91% | Mar 9, 2026 |